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Iodoacetamide (IAA) and iodoacetate (IA) have frequently been used to inhibit glycolysis, 
since these compounds are known for their ability to irreversibly inhibit the glycolytic enzyme 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). However, the consequences of a 
treatment with such thiol reagents on the glutathione (GSH) metabolism of brain cells have not 
been explored. Exposure of astroglia-rich primary cultures to IAA or IA in concentrations of up 
to 1 mM deprived the cells of GSH, inhibited cellular GAPDH activity, lowered cellular lactate 
production and caused a delayed cell death that was detectable after 90 min of incubation. 
However, the two thiol reagents differed substantially in their potential to deprive cellular GSH 
and to inhibit astrocytic glycolysis. IAA depleted the cellular GSH content more efﬁ  ciently than 
IA as demonstrated by half-maximal effects for IAA and IA that were observed at concentrations 
of about 10 and 100 µM, respectively. In contrast, IA was highly efﬁ  cient in inactivating GAPDH 
and lactate production with half-maximal effects observed already at a concentration below 
100 µM, whereas IAA had to be applied in 10 times higher concentration to inhibit lactate 
production by 50%. These substantial differences of IAA and IA to affect GSH content and 
glycolysis of cultured astrocytes suggest that in order to inhibit astrocytic glycolysis without 
substantially compromising the cellular GSH metabolism, IA – and not IAA – should be used 
in low concentrations and/or for short incubation periods.
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excluded. In this context, especially the reactions of IAA and IA 
with low molecular weight cellular thiols such as GSH (Chen and 
Stevens, 1991; Liu et al., 1996) have to be considered.
The tripeptide GSH (γ-L-glutamyl-L-cysteinylglycine) is a cel-
lular thiol that is present in millimolar concentrations in mam-
malian cells (Cooper and Kristal, 1997). GSH has many important 
functions in cells. Among those, the antioxidative and detoxifying 
functions of GSH are most likely the most important ones for 
many cell types and tissues. GSH serves as electron donor for the 
reduction of peroxides by glutathione peroxidases (Margis et al., 
2008) and is substrate for the detoxiﬁ  cation of xenobiotics in the 
reactions that are catalyzed by glutathione-S-transferases (Hayes 
et al., 2005).
In the brain, astrocytes play a very important role in the anti-
oxidative defense and in the detoxiﬁ  cation of xenobiotics (Aoyama 
et al., 2008; Ballatori et al., 2008; Cooper and Kristal, 1997; Dringen, 
2000, 2009). Cultured astrocytes contain GSH in a cytosolic concen-
tration of 8 mM (Dringen and Hamprecht, 1998). These cells rely 
on a high GSH concentration for the rapid clearance of   peroxides 
(Dringen et al., 2005; Liddell et al., 2006a,b) for the resistance 
against oxidative stress (Bi et al., 2008; Bishop et al., 2007; Gegg 
et al., 2003, 2005; Giordano et al., 2008) and for the GSH- dependent 
detoxiﬁ  cation of xenobiotics (Kubatova et al., 2006; Sagara and 
Sugita, 2001; Waak and Dringen, 2006).
Although IAA and IA have often been used to modulate the 
glucose metabolism of cultured astrocytes, the consequences of a 
INTRODUCTION
The thiol reagents iodoacetamide (IAA) and iodoacetate (IA) 
(Figure 1) are frequently used as alkylating reagents to modify 
thiol groups in proteins by S-carboxyamidomethylation and 
S-carboxymethylation, respectively. IAA and IA have been used to 
study the importance of cysteine residues in catalytic reactions of 
enzymes and in transport processes of brain cells (Albrecht et al., 
1993; Aschner et al., 1994; Gali and Board, 1997) and to derivatise 
cysteine residues in proteins for proteomic approaches (Adachi 
et al., 2005; Sun et al., 2008; Williams et al., 2008). The inactivation 
of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by IAA 
and IA (Sabri and Ochs, 1971; Williamson, 1967) is often used 
as text book example for an irreversible enzyme inhibition. The 
essential cysteine residue in the active center of GAPDH forms a 
thioether bond with IAA or IA and can therefore not react anymore 
with the physiological substrate glyceraldehyde-3-phosphate. As a 
consequence, GAPDH is inactivated after exposure to IAA or IA 
and glycolysis is inhibited.
On cultured astrocytes and glial cell lines, IAA and IA have been 
used to inhibit glycolysis (Bakken et al., 1998; Bickler and Kelleher, 
1992; Gemba et al., 1994; Loreck et al., 1987; Ogata et al., 1995) 
and to study the consequences of ATP depletion and hypoglycemia 
(Kauppinen et al., 1988; Nodin et al., 2005; Parkinson et al., 2002; 
Sun et al., 1993; Taylor et al., 1996). However, during treatment 
of cells or tissue with IAA or IA, side effects that are caused by 
the unspeciﬁ  c reaction of IAA and IA as thiol reagents cannot be 
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treatment of astrocytes with such thiol reagents on the GSH content 
of the cells have not been reported. Here we describe that exposure 
of cultured astrocytes to IAA or IA lowers the cellular GSH con-
tent and inhibits glycolysis, but that the two thiol reagents differ 
strongly in their potential to do so. IA is highly efﬁ  cient in low 
concentrations to inhibit GAPDH activity and to lower cellular 
lactate production of cultured astrocytes, whereas IAA is much 
more potent to deprive cells of GSH than to inactivate glycolysis. 
These results suggest that for experiments that require inhibition 
of glycolysis in astrocytes IA – but not IAA – should be used in 
micromolar concentrations or only for short incubation periods to 
avoid a severe compromise of cellular GSH metabolism.
MATERIALS AND METHODS
MATERIALS
IAA, IA and 5,5′-dithio-bis(2-nitrobenzoic acid) were obtained from 
Sigma-Aldrich (Steinheim, Germany). Glucose-6-phosphate, gluta-
mate pyruvate transaminase, GSH, glutathione disulﬁ  de (GSSG), 
glutathione reductase (GR), glyceraldehyde-3-phosphate, lactate 
dehydrogenase (LDH), maleimide and potassium arsenate were 
from Roche Diagnostics (Mannheim, Germany). Bovine serum 
albumin, NAD+, NADH, NADP+, NADPH and sulfosalicylic acid 
were purchased from Applichem (Darmstadt, Germany). Fetal calf 
serum, streptomycin sulfate and penicillin G were from Biochrom 
(Berlin, Germany). Dulbecco’s modiﬁ  ed Eagle’s medium (DMEM) 
was purchased from Invitrogen (Karlsruhe, Germany). All other 
chemicals were obtained from Fluka (Buchs, Switzerland) or Merck 
(Darmstadt, Germany) at analytical grade. Sterile cell culture 
material and unsterile 96-well plates were from Nunc (Roskilde, 
Denmark) and Sarstedt (Karlsruhe, Germany).
CELL CULTURES
Astroglia-rich primary cultures derived from the whole brains 
of neonatal Wistar rats were prepared as previously described 
(Hamprecht and Löfﬂ  er, 1985). Three hundred thousand viable 
cells were seeded per well of a 24-well dish in 1 mL culture medium 
(90% DMEM, 10% fetal calf serum, 20 U/mL of penicillin G and 
20 µg/mL of streptomycin sulfate) and cultured in a cell incubator 
(Sanyo, Osaka, Japan) that contained a humidiﬁ  ed atmosphere of 
10% CO2/90% air. The culture medium was renewed every seventh 
day. The results described here were obtained on 14- to 23-day-old 
cultures.
EXPERIMENTAL INCUBATION OF CELLS
To study the consequences of a treatment of astrocytes with IAA or 
IA, the cells were washed with 1 mL of prewarmed (37°C) incuba-
tion buffer (IB; 1.8 mM CaCl2, 1 mM MgCl2, 5.4 mM KCl, 145 mM 
NaCl, 0.8 mM Na2HPO4, 20 mM HEPES, 5 mM d-Glucose, pH 7.4) 
and incubated in the cell incubator with 0.5 mL IB containing IAA 
or IA in the concentrations given in the ﬁ  gures. For analysis of the 
total cellular glutathione content (GSx = amount of GSH plus twice 
the amount of GSSG), the cells were washed with 1 mL phosphate-
buffered saline (PBS; 10 mM potassium phosphate buffer, 150 mM 
NaCl, pH 7.4) and lysed with 0.5 mL 1% (w/v) sulfosalicylic acid. 
Ten microliters of aliquote parts of the lysates were used to quantify 
the cellular GSx content.
CHEMICAL REACTION OF GSH WITH IAA OR IA
GSH (10 µM) was incubated with the indicated concentrations 
of IAA or IA in a total volume of 1 mL at room temperature in 
IB for up to 60 min. At the time points indicated, 10 µL sample of 
the reaction mixture were mixed with 10 µL 1% sulfosalicylic acid 
before the GSx content was determined as described below.
DETERMINATION OF GLUTATHIONE
The contents of GSx and GSSG in cell lysates and incubation media 
were determined as described previously (Dringen and Hamprecht, 
1996; Dringen et al., 1997) in microtiter plates according to the 
colorimetric method originally described by Tietze (Tietze, 1969). 
The detection limit of this assay was about 0.2 nmol GSx per 500 µL 
lysate or medium.
DETERMINATION OF LACTATE IN CULTURE MEDIUM
Extracellular lactate concentration in culture media was determined 
using a modiﬁ  cation of an established assay (Dringen et al., 1993). 
Brieﬂ  y, 20 µL media sample were diluted with 160 µL puriﬁ  ed 
water in wells of a microtiter plate and mixed with 180 µL reac-
tion mixture (5.6 mM NAD+, 19.9 U/mL LDH, 1.94 U/mL gluta-
mate pyruvate transaminase in 250 mM glutamate/NaOH buffer, 
pH 8.9). After incubation for 90 min in a humidiﬁ  ed atmosphere 
at 37°C the absorbance of the NADH generated from lactate was 
determined at 340 nm using a Sunrise microtiter plate photometer 
(Tecan, Austria). Media samples containing no lactate were used 
as blanks.
DETERMINATION OF ENZYME ACTIVITIES
The cells were washed with 1 mL ice-cold PBS and subsequently 
lysed by incubation with 200 µL 20 mM potassium phosphate 
buffer (pH 7.0) for 10 min on ice. The lysates were scrapped of 
the wells and transferred into Eppendorf cups. After centrifugation 
(1 min, 12,000g, room temperature) 20 µL volumes of the superna-
tant were used to determine enzyme activities in wells of microtiter 
plates at room temperature. GAPDH activity was determined using 
the method described by Bisswanger (2004). The reaction mixture 
contained in a total volume of 360 µL 0.9 mM glyceraldehyde-3-
phosphate, 3 mM potassium dihydrogen arsenate, 2 mM NAD+ 
and 93 mM triethylamine hydrochloride/NaOH buffer, pH 7.6. The 
increase of absorbance at 340 nm due to the reduction of NAD+ 
to NADH was followed over 10 min time. Glucose-6-phosphate 
dehydrogenase (G6PDH) activity was determined according to 
Deutsch (1984). The reaction mixture contained in a total volume 
of 200 µL 6.3 mM MgCl2, 5 mM maleimide, 3.3 mM glucose-6-
phosphate, 0.4 mM NADP+ and 75 mM Tris/HCl buffer, pH 7.5. 
The increase of absorbance at 340 nm due to the reduction of 
NADP+ to NADPH was followed over 5 min. LDH activity was 
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determined using the method described previously (Dringen et al., 
1998). The reaction mixture contained in a total volume of 360 µL 
1.8 mM pyruvate, 0.2 mM NADH and 80 mM Tris/HCl buffer 
containing 200 mM NaCl, pH 7.2. The decrease of absorbance 
at 340 nm due to the oxidation of NADH to NAD+ was followed 
over 5 min. GR activity was determined using a method described 
previously (Gutterer et al., 1999). The reaction mixture contained 
in a total volume of 300 µL 1 mM GSSG, 0.2 mM NADPH and 
1 mM EDTA in 100 mM potassium phosphate buffer, pH 7.0. The 
decrease of absorbance at 340 nm due to the oxidation of NADPH 
was followed over 5 min.
DETERMINATION OF CELL VIABILITY AND PROTEIN CONTENT
Loss of cell viability was analyzed by comparing the activity of 
LDH in the incubation medium with that of the cells using the 
microtiter plate assay described previously (Dringen et al., 1998). 
The presence of IAA or IA in a concentration of 1 mM did not affect 
LDH activity in lysates of cultured astrocytes (data not shown). 
The protein content per well of a 24-well dish was quantiﬁ  ed after 
solubilization of the cells in 200 µL of 0.5 M NaOH according to 
the Lowry method (Lowry et al., 1951) using bovine serum albumin 
as a standard. Total protein content per well and cytosolic protein 
in the supernatants of cell lysates (cytosolic protein) were used 
to calculate speciﬁ  c GSx or GSSG contents and speciﬁ  c enzyme 
activities, respectively.
PRESENTATION OF THE DATA
If not stated otherwise, the data are presented as mean ± SD of 
values obtained in experiments on three independently prepared 
cultures. In the ﬁ  gures the bars have been omitted if they were 
smaller than the symbols representing the mean values. Statistical 
analysis of the signiﬁ  cance of differences between multiple sets 
of data were performed by ANOVA followed by Bonferroni post 
hoc test. If not stated otherwise, statistical analysis of the signiﬁ  -
cance of differences between two sets of data was performed using 
the paired t-test. The data shown in Figure 2 for IAA and IA were 
obtained separately and were therefore analyzed for signiﬁ  cance by 
the unpaired t-test. p > 0.05 was considered as not signiﬁ  cant.
RESULTS
CHEMICAL REACTION OF IAA OR IA WITH GSH
To test whether IAA and IA react chemically with GSH, IAA or IA 
were mixed with GSH and the amount of detectable GSx was deter-
mined during an incubation period of up to 60 min. In the presence 
of IAA (Figure 2A) or IA (Figure 2B) the amount of detectable 
GSx was lowered in a time- and concentration-dependent manner. 
For all concentrations of IAA or IA applied, the amount of GSx 
determined after 60 min of incubation was signiﬁ  cantly lower after 
treatment with IAA than after exposure to IA (Figure 2C). Half-
maximal effects on the GSx content after 60 min of incubation 
with IAA and IA were observed for concentrations of about 0.2 
and 1 mM, respectively (Figure 2C), demonstrating that IAA was 
more potent to react with GSH than IA.
INACTIVATION OF ASTROCYTIC GAPDH BY IAA OR IA
IAA and IA are well known to inhibit GAPDH activity (Sabri and 
Ochs, 1971; Williamson, 1967). To test for the potential of these 
compounds to inactivate astrocytic GAPDH, cultured astrocytes 
were lysed and the GAPDH activity in the lysates was determined 
in the absence or presence of IAA or IA. In the absence of IAA and 
IA, the increase in absorbance that was caused by the GAPDH-
dependent formation of NADH was almost linear for up to 30 min 
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FIGURE 2 | Disappearance of GSH after exposure to IAA or IA. GSH in a 
concentration of 10 µM was incubated with the indicated concentrations of 
IAA (A) or IA (B) for up to 60 min. (C) shows the GSx content that was 
detected after 60 min incubation with the given concentrations of IAA or IA. 
The data shown represent mean ± SD of 6 values that were obtained in two 
independent experiments, each performed in triplicates with individually 
prepared solutions. The signiﬁ  cance of the differences between the values 
obtained for IAA and IA was calculated by the unpaired t-test and is indicated 
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(Figure 3). If the GAPDH reaction was monitored in the presence 
of IAA, the increase in NADH absorbance during the ﬁ  rst 20 min of 
incubation was not signiﬁ  cantly different (p > 0.05) from that of the 
control condition (absence of inhibitor) and it took about 60 min 
before the enzyme was completely inhibited (Figure 3). In contrast, 
in the presence of IA the increase in NADH absorbance was com-
pletely prevented within a few minutes (Figure 3).
CONSEQUENCES OF A TREATMENT OF ASTROCYTE CULTURES WITH 
IAA OR IA
To test for the consequences of a treatment of cultured astrocytes 
with IAA or IA, the cells were incubated with various concentrations 
of these compounds for up to 2 h. After the indicated incubation 
times the extracellular activity of LDH as indicator for the loss of 
cell viability, the speciﬁ  c cellular GSx content as indicator for cel-
lular GSH, and the lactate concentration in the medium as indicator 
for glycolytic activity were monitored.
During the ﬁ  rst 60 min of incubation with IAA or IA, the cells 
remained viable as indicated by the lack of any increase (p > 0.05) 
in extracellular LDH activity compared to control (absence of IAA 
and IA) (Figures 4A,B). However, incubation of astrocytes with 
IAA or IA for longer than 60 min caused a signiﬁ  cant increase in 
extracellular LDH activity that was moderate for 0.1 mM IAA or 
IA but more severe for higher concentrations of both compounds 
(Figures 4A,B).
Exposure of cultured astrocytes to IAA caused a rapid decline of 
the cellular speciﬁ  c GSx content (p < 0.001 already after 5 min) that 
resulted after 30 min incubation in cellular GSx levels below 20% 
of control (absence of IAA) (Figure 4C). Also IA caused a decline 
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FIGURE 3 | GAPDH activity in cell lysates of astrocyte cultures in the 
absence or the presence of IAA or IA. The absorbance at 340 nm that 
indicates the formation of NADH by GAPDH was monitored. The results are 
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from three independently prepared cultures.
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Exposure of astrocytes to IAA hardly affected the   extracellular 
accumulation of lactate during the ﬁ  rst 60  min of incubation 
compared to control (Figure 6A), whereas a further increase of 
extracellular lactate was slowed during longer incubations, at least 
for IAA concentrations of 0.3 and 1 mM (Figure 6A). The extracel-
lular lactate concentration determined for cells that were treated 
with IAA for 60 min did not differ signiﬁ  cantly to that of control 
cells (Figure 7A). In contrast, incubation of astrocytes with IA in 
a concentration of 1 mM inhibited extracellular lactate accumu-
lation much quicker than IAA (Figure 6B). In concentrations of 
0.1 or 0.3 mM IA almost completely prevented extracellular lac-
tate accumulation within 30 min of incubation (Figure 6B). After 
60 min of incubation the extracellular lactate concentrations of 
astrocyte cultures that were treated with 0.1, 0.3 and 1 mM IA were 
 signiﬁ  cantly lowered to 40 ± 7, 24 ± 16 and 6 ± 8%, respectively, of 
the concentration determined for cells that were incubated without 
inhibitor (Figure 7A).
To demonstrate that indeed the inhibition of GAPDH by IAA 
or IA was responsible for the observed decline in the rate of glyco-
lytic lactate production in astrocyte cultures, the speciﬁ  c activity of 
GAPDH was determined for cells that were treated for 60 min with 
various concentrations of IAA or IA. When the cells were exposed to 
0.1 mM IAA the speciﬁ  c GAPDH activity was signiﬁ  cantly lowered 
to half of that of controls (Figure 7B). In contrast, already after 
treatment of the cells with 0.1 mM IA for 60 min GAPDH activity 
was not detectable anymore (Figure 7B). In concentrations of 0.3 
and 1 mM, both IAA and IA completely inhibited GAPDH activity 
of astrocyte cultures within 60 min of incubation (Figure 7B).
To analyze how quickly the cellular GAPDH activity of cultured 
astrocytes was inactivated after exposure to IAA or IA, the cells 
were incubated with various concentrations of IAA or IA for time 
periods in the minute range (Figure 8). Half-maximal inhibition 
of astrocytic GAPDH by IAA that was applied in concentrations 
of 0.1, 0.3 and 1 mM was observed after about 60, 30 and 5 min of 
incubation, respectively (Figure 8A). In contrast, inactivation of 
GAPDH by the presence of IA was much faster that that by IAA. 
GAPDH activity was not detectable anymore after exposure of the 
cells for 5, 15 and 30 min to IA in concentrations of 1, 0.3 and 
0.1 mM, respectively (Figure 8B).
To test whether IAA or IA are also able to inactivate other meta-
bolic enzymes in cultured astrocytes, the cells were exposed for 
60 min to IAA or IA in concentrations of 1 mM. Although these 
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FIGURE 5 | Concentration dependency of the GSH depletion by IAA or IA 
in cultured astrocytes. The cells were incubated for 60 min with IAA or IA in 
concentrations of up to 1 mM. The results represent mean ± SD of data that 
were obtained on three independently prepared cultures that contained 
80 ± 8 µg protein per well. The initial speciﬁ  c GSx content (100%) 
corresponded to 46.2 ± 10.2 nmol/mg protein. The signiﬁ  cance of differences 
to the data obtained for the control condition (absence of inhibitor) are 
indicated by *p < 0.05, **p < 0.01 or ***p < 0.001. The signiﬁ  cance of 
differences between the data observed after treatment with identical 
concentrations of IAA and IA was calculated by the paired t-test and is 
indicated by ###p < 0.001.
in cellular GSx content that depended on the concentration of IA 
applied (Figure 4D). However, this decline in cellular GSx after IA 
application (Figure 4D) was much slower than that observed for 
identical concentrations of IAA (Figure 4C) (p < 0.001 after 5 min 
for all concentrations of IAA and IA applied). The concentrations 
causing half-maximal deprivation of cellular GSx after exposure 
of cultured astrocytes for 60 min to IAA and IA were about 10 
and 100 µM, respectively, and differed by one order of magnitude 
(Figure 5).
The decline in cellular GSx that was observed after exposure 
of cultured astrocytes to IAA or IA (Figures 4C,D and 5) was not 
accompanied by an increase in cellular GSSG nor by an increase 
in the extracellular concentrations of GSx or GSSG (Table 1). In 
contrast, the extracellular contents of GSx and GSSG were lowered 
after incubation of the cells with IAA or IA (Table 1).
Table 1 | Cellular and extracellular GSx and GSSG contents and extracellular LDH activity of primary astrocyte cultures after exposure to IAA or IA.
 Control  IAA  IA  n
Cellular GSx (nmol/mg)  41.9 ± 7.6  3.1 ± 3.6***  8.9 ± 5.6***  4
Cellular GSSG (nmol/mg)  5.1 ± 0.6  2.0 ± 2.0  2.9 ± 1.1  3
Extracellular GSx (nmol/mg)  4.7 ± 0.5  1.4 ± 1.1*  2.4 ± 1.4  3
Extracellular GSSG (nmol/mg)  3.8 ± 0.5  1.6 ± 0.9*  2.6 ± 0.9  3
Extracellular LDH  (%)  6.4 ± 1.8  12.2 ± 6.5  8.9 ± 2.2  4
Primary astrocyte cultures were incubated in the absence (control) or the presence of 1 mM IAA or IA. The cellular and extracellular contents of GSx and GSSG and 
extracellular LDH activity (as % of initial) were determined after 60 min of incubation. The results represent mean ± SD of data that were obtained on n independently 
prepared cultures that contained 87 ± 16 µg protein per well. The signiﬁ  cance of differences to the data obtained for the control condition (absence of inhibitor) are 
indicated by *p < 0.05 or ***p < 0.001.Frontiers in Neuroenergetics  www.frontiersin.org  March  2009 | Volume  1 | Article  1 | 6
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high concentration of IAA or IA completely inactivated GAPDH 
(Figure 8; Table 2), they had no signiﬁ  cant effect on the speciﬁ  c 
activities of G6PDH or LDH. However, 60  min incubation of 
  cultured astrocytes with 1 mM of IAA signiﬁ  cantly lowered the 
speciﬁ  c activity of GR to 45% of controls (Table 2), whereas treat-
ment of astrocytes with 1 mM of IA caused only some decline 
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FIGURE 7 | Consequences of a treatment of cultured astrocytes with IAA 
or IA on the extracellular lactate concentration (A) and on the speciﬁ  c 
cellular GAPDH activity (B). The cells were incubated for 60 min 
with IAA or IA in concentrations of up to 1 mM. The results represent 
mean ± SD of data that were obtained on three (A) or six (B) independently 
prepared cultures that contained 80 ± 8 µg total protein per well 
(A) or 37 ± 11 µg cytosolic protein per well (B). The signiﬁ  cance of differences 
to the data obtained for the control condition (absence of inhibitor) 
are indicated by **p < 0.01 or ***p < 0.001. The signiﬁ  cance of differences 
between the data observed after treatment with identical concentrations of IAA 
and IA was calculated by the paired t-test and is indicated by #p < 0.05 or 
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in GR activity that did not reach the level of signiﬁ  cance for the 
conditions investigated (Table 2).
DISCUSSION
The thiol reagents IAA and IA have frequently been used to inhibit 
astrocytic glycolysis (Bakken et al., 1998; Bickler and Kelleher, 1992; 
Gemba et al., 1994; Loreck et al., 1987; Ogata et al., 1995), but no 
information has been reported whether such treatments also affect 
the cellular GSH metabolism of astrocytes. To test for the conse-
quences of a treatment of cultured astrocytes with IAA or IA on 
the GSH metabolism, the cells were exposed to various concen-
trations of the thiol reagents for up to 120 min. During the ﬁ  rst 
60 min incubation with IAA or IA in concentrations of up to 1 mM 
the cells remained viable as indicated by the lack of extracellular 
LDH activity, although glycolysis was inhibited and the cells were 
deprived of GSH. This lack of acute toxicity of such thiol reagents 
on cultured astrocytes conﬁ  rms literature data (Gemba et al., 1994; 
Kahlert and Reiser, 2004; Nodin et al., 2005).
Comparison of the potential of IAA and IA to deprive cells of 
GSH and to inhibit glycolysis revealed substantial differences that 
have to our knowledge not been described so far. IAA was highly 
efﬁ  cient to deprive the cells of GSH, whereas IA quickly inactivated 
GAPDH activity and slowed glycolysis. These differential effects 
are best demonstrated by the concentrations of the thiol reagents 
that had to be applied to obtain half-maximal effects for IAA and 
IA on GSH deprivation and lactate production which differed in 
both cases by one order of magnitude.
The GSH content of cultured astrocytes was lowered after expo-
sure to IAA or IA. Such a decline of cellular non protein thiols 
has also been described for the kidney proximal tubule cell line 
LLC-PK1 after treatment with IAA (Chen and Stevens, 1991; Liu 
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FIGURE 8 | Time dependency of the inhibition of GAPDH by IAA or 
IA in cultured astrocytes. The cells were incubated for up to 60 min 
without (circles) or with IAA (A) or IA (B) in concentrations of 0.1 mM 
(triangles), 0.3 mM (squares) or 1 mM (diamonds). The results represent 
mean ± SD of data that were obtained on three independently prepared 
cultures that contained 45 ± 5 µg cytosolic protein per well. The initial 
speciﬁ  c GAPDH activity (100%) corresponded to 492 ± 45 nmol/(min × mg) 
cytosolic protein. The signiﬁ  cance of differences to the data obtained for the 
control condition (absence of inhibitor) are indicated by **p < 0.01 or 
***p < 0.001.
Table 2 | Speciﬁ  c activities of enzymes in cultured astrocytes after 
exposure to IAA or IA.
Enzyme  Inhibitor  Enzyme activity (nmol/(min ×  × mg))  n
GAPDH None  339  ± 145  6
 IAA  8  ± 13***  6
 IA  4  ± 4***  6
G6PDH None  108  ± 12  3
 IAA  96  ± 8  3
 IA  104  ± 10  3
GR None  56  ± 3  3
 IAA  25  ± 12*  3
 IA  40  ± 6  3
LDH None  3278  ± 374  3
 IAA  3798  ± 379  3
 IA  3832  ± 331  3
Primary astrocyte cultures were incubated in the absence or the presence of 
1 mM of IAA or IA. After 60 min incubation, the cells were lysed and the speciﬁ  c 
activities of the enzymes glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
glucose-6-phosphate dehydrogenase (G6PDH), lactate dehydrogenase (LDH) and 
glutathione reductase (GR) were determined. The results represent mean ± SD 
of data that were obtained on n independently prepared cultures that contained 
45 ± 5 µg (n = 3) or 37 ± 11 µg (n = 6) cytosolic protein per well. The signiﬁ  cance 
of differences to the data obtained for the control condition (none) is indicated 
by *p < 0.05 or ***p < 0.001.Frontiers in Neuroenergetics  www.frontiersin.org  March  2009 | Volume  1 | Article  1 | 8
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et al., 1996). The deprivation of cellular GSH after exposure to IAA 
or IA is most likely the direct consequence of the alkylation of GSH 
in viable cells, since both IAA and IA reacted also efﬁ  ciently with 
GSH in a cell-free system in a time- and concentration-dependent 
manner. Loss of cellular GSx that is caused by damage of the cell 
membrane after exposure to IAA or IA or by an elevated export 
of GSH or GSSG from cultured astrocytes (Hirrlinger et al., 2001, 
2002; Minich et al., 2006) can be excluded for the conditions used 
here, since an increased extracellular accumulation of GSx or GSSG 
was not observed.
The cellular GSH concentration of cultured astrocytes was 
quicker deprived by exposure to IAA than by treatment with IA. 
This difference is likely to reﬂ  ect different chemical reactivity of 
IAA and IA with GSH, since IAA was also in cell-independent 
experiments more potent than IA to react with GSH. The reaction 
of a thiol with IAA or IA is initiated by a nucleophilic attack of the 
sulfhydryl group to the α-carbon of IAA or IA. Since the α- carbon 
of IA is less positive than that of IAA due to the neighboring nega-
tive carboxylate in IA compared to the uncharged carboxyamido 
group in IAA, IA will alkylate the thiol group of GSH less efﬁ  -
ciently than IAA. Also differences in cellular uptake of IAA and 
IA could contribute at least in part to the observed    differences 
in the    potential of IAA and IA to deprive cultured astrocytes of 
their GSH. Different mechanisms of uptake of the uncharged IAA 
and the negatively charged IA could result in a higher cellular con-
centration of IAA, thereby further accelerating the chemical reac-
tion of cellular GSH with IAA. However, the quick inhibition of 
GAPDH that was observed after exposure of cultured astrocytes 
to IA clearly demonstrates that the charged IA does enter the cells 
and that    cellular IA concentrations are quickly reached that are 
sufﬁ  cient to efﬁ  ciently inhibit GAPDH.
Despite of its stronger reactivity toward GSH, IAA appears to 
be a less potent inhibitor of astrocytic glycolysis than IA. Already 
low concentrations of IA were highly efﬁ  cient to inactivate GAPDH 
and to prevent lactate production by cultured astrocytes. Different 
rates of transport of IAA and IA can be excluded as explanation of 
this observation, since IA was also much more potent than IAA to 
inactivate GAPDH in cell lysates and since the quick deprivation 
of cellular GSH clearly demonstrates that IAA is efﬁ  ciently taken 
up by the cells.
Reasons for this difference of IA and IAA to inactivate GAPDH 
could be that the active center of the enzyme binds the negatively 
charged IA better than the neutral IAA and/or that for sterical 
reasons IA ﬁ  ts better than IAA into the active side of GAPDH 
in an orientation that facilitates the alkylation of the thiol group 
in the active center. Alternatively, the alkylation of the astrocytic 
GAPDH by IAA and IA could be inversely modulated by the 
GAPDH cosubstrate NAD+. At least for yeast GAPDH was reported 
that the presence of NAD+ supports alkylation by IA but inhibits 
alkylation by IAA (Byers and Koshland Jr., 1975). Such a behav-
ior would explain the different potential of IAA and IA to inhibit 
GAPDH in astrocytic lysates, since the NAD+ concentration in the 
GAPDH activity assay used was 2 mM, a concentration that has 
been reported to support alkylation of yeast GAPDH by IA and to 
suppress   alkylation by IAA (Byers and Koshland Jr., 1975). With 
a speciﬁ  c NAD+ content of about 1.5 nmol/mg protein (X. Chen 
and R. Dringen, unpublished results) and a cytosolic volume of 
4.1 µL/mg protein (Dringen and Hamprecht, 1998), the cytosolic 
NAD+ concentration of cultured astrocytes is about 0.4 mM. This 
concentration of NAD+ may already be sufﬁ  cient to support alkyla-
tion of GAPDH from IA in living astrocytes, whereas the alkylation 
from IAA is slowed down.
Regarding the inhibition of enzymes in viable astrocytes, IAA 
and IA appear to be remarkable speciﬁ  c for GAPDH. The highly 
reactive thiol group in the active center of GAPDH appears to 
be an excellent target to become alkylated by these thiol reagents. 
In contrast, other dehydrogenases such as G6PDH or LDH were 
not inactivated by exposure of astrocytes to 1 mM of IAA or IA. 
Only the cellular GR activity was partly inactivated by IAA. This 
slow but signiﬁ  cant inactivation of GR conﬁ  rms literature data that 
demonstrate that at least puriﬁ  ed GR is sensitive to inactivation 
by IAA (Arscott et al., 1981; Pai and Schulz, 1983; Untucht-Grau 
et al., 1981). Thus, the quick depletion of cellular GSH appears to 
be the strongest side effect of a treatment of cultured astrocytes 
with 1 mM of IAA or IA.
Incubation of cultured astrocytes with IAA or IA caused severe 
cell death after incubation of the cells for more than 60 min with 
the thiol reagents. Both the inhibition of glycolysis and the decline 
in cellular GSH could contribute to the observed toxicity of IAA 
and IA after longer exposure to astrocytes. Since cultured astrocytes 
are able to survive depletion of their cellular GSH for several hours 
(Waak and Dringen, 2006), the cellular GSH deprivation appear not 
to be the primary cause of the delayed cell death observed after 
treatment with the thiol reagents. It is more likely that the deple-
tion of cellular ATP that has been reported for cultured brain cells 
at least for the treatment with IA (Hernandez-Fonseca et al., 2008; 
Nodin et al., 2005; Ogata et al., 1995) is responsible for the observed 
cell death after exposure to IAA or IA.
IAA and IA are frequently used to slow glycolysis by inhibiting 
the GAPDH in cultured astrocytes. For such studies millimolar 
concentrations of IAA or IA have been used for incubation periods 
above 5 min [10 mM IAA for 2.5 h (Loreck et al., 1987), 3.5 mM 
IA for 15 min (Bickler and Kelleher, 1992), 1 mM IA for 30 min 
(Gemba et al., 1994), 5 mM IA for 30 min (Ogata et al., 1995)]. 
In our hands, such conditions deprive cultured astrocytes quickly 
of GSH. Thus, a contribution of a compromised cellular GSH 
metabolism to the reported effects observed after treatment of cul-
tured astrocytes with millimolar concentrations of IAA or IA has to 
be considered. Since IAA lowers quickly the cellular GSH content 
of cultured astrocytes, we recommend not to use this compound 
for inactivation of GAPDH and glycolysis. In contrast to IAA, IA 
lead to a quick inactivation of GAPDH activity and slows down 
lactate production, without affecting the cellular GSH content 
substantially. Therefore, we suggest to use a low concentration of 
IA (0.1 mM) for 30 min or a high concentration of IA (1 mM) 
for 5 min to inhibit glycolysis in cultured astrocytes, since these 
conditions do not substantially compromise the GSH metabolism 
of the cells.Frontiers in Neuroenergetics  www.frontiersin.org  March  2009 | Volume  1 | Article  1 | 9
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